MX19599A - Procedimiento para la preparacion de nuevos 19-nor-esteroides que tienen en posicion 11-beta una cadena carbonada que comprende una funcion amida o carbamato, productos obtenidos y composiciones farmaceuticas preparadas con el producto obtenido. - Google Patents

Procedimiento para la preparacion de nuevos 19-nor-esteroides que tienen en posicion 11-beta una cadena carbonada que comprende una funcion amida o carbamato, productos obtenidos y composiciones farmaceuticas preparadas con el producto obtenido.

Info

Publication number
MX19599A
MX19599A MX19599A MX1959990A MX19599A MX 19599 A MX19599 A MX 19599A MX 19599 A MX19599 A MX 19599A MX 1959990 A MX1959990 A MX 1959990A MX 19599 A MX19599 A MX 19599A
Authority
MX
Mexico
Prior art keywords
alkyl
optionally
preparation
amida
steroids
Prior art date
Application number
MX19599A
Other languages
English (en)
Inventor
Andre Claussner
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of MX19599A publication Critical patent/MX19599A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención tiene por objeto un procedimiento para preparar los compuestos de fórmula (I). La invención tiene principalmente por objeto un procedimiento para preparar los compuestos de fórmula (I ') tal como se han definido antes, que responden a la fórmula (I).
MX19599A 1989-02-24 1990-02-21 Procedimiento para la preparacion de nuevos 19-nor-esteroides que tienen en posicion 11-beta una cadena carbonada que comprende una funcion amida o carbamato, productos obtenidos y composiciones farmaceuticas preparadas con el producto obtenido. MX19599A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8902384A FR2643638B1 (fr) 1989-02-24 1989-02-24 Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
MX19599A true MX19599A (es) 1994-04-29

Family

ID=9379072

Family Applications (1)

Application Number Title Priority Date Filing Date
MX19599A MX19599A (es) 1989-02-24 1990-02-21 Procedimiento para la preparacion de nuevos 19-nor-esteroides que tienen en posicion 11-beta una cadena carbonada que comprende una funcion amida o carbamato, productos obtenidos y composiciones farmaceuticas preparadas con el producto obtenido.

Country Status (23)

Country Link
US (2) US5149696A (es)
EP (1) EP0384842B1 (es)
JP (1) JP3009169B2 (es)
KR (1) KR910015590A (es)
CN (1) CN1046166A (es)
AT (1) ATE99320T1 (es)
AU (1) AU631853B2 (es)
CA (1) CA2010826A1 (es)
DE (1) DE69005480T2 (es)
DK (1) DK0384842T3 (es)
ES (1) ES2062431T3 (es)
FI (1) FI900925A0 (es)
FR (1) FR2643638B1 (es)
HU (1) HU207341B (es)
IE (1) IE63483B1 (es)
IL (1) IL93500A0 (es)
MA (1) MA21754A1 (es)
MX (1) MX19599A (es)
OA (1) OA09195A (es)
PL (1) PL162151B1 (es)
PT (1) PT93263B (es)
TN (1) TNSN90018A1 (es)
ZA (1) ZA901356B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2650748B1 (fr) * 1989-08-08 1991-11-08 Roussel Uclaf Nouveaux esters d'acides organiques avec des alcools derives de 19-nor steroides et leurs sels, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions les renfermant
DK0471612T3 (da) * 1990-08-14 1999-02-22 Hoechst Marion Roussel Inc Nye 19-nor steroider med carbonkæde omfattende en amidgruppe i 11-beta-stillingen, fremgangsmåde til deres fremstilling, de
GB9126766D0 (en) * 1991-12-17 1992-02-12 Coombes Raoul C D Pharmaceutical compositions
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.
FR2700548B1 (fr) * 1993-01-20 1995-03-03 Roussel Uclaf Nouveau procédé de préparation de stéroïdes 16 alpha-méthylés.
FR2706454B1 (fr) * 1993-06-17 1995-09-15 Roussel Uclaf Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant.
DE69500542T2 (de) * 1994-05-19 1998-01-02 Akzo Nobel Nv 11,21-Bisphenyl-19-nor-pregnan Derivate
JP3744559B2 (ja) * 1995-03-17 2006-02-15 独立行政法人情報通信研究機構 立体カメラ、立体ディスプレイ、及び、立体映像システム
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
DE19724187A1 (de) 1997-06-02 1998-12-03 Schering Ag 11beta-Arylsubstituierte 14,17-Ethanoestratriene, Verfahren zur Herstellung dieser Verbindungen, sowie ihre Verwendung zur Herstellung von Arzneimitteln
FR2771096B1 (fr) * 1997-11-17 2000-08-11 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides, substitues en position 11beta, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
FR2789993B1 (fr) * 1999-02-22 2003-03-07 Hoechst Marion Roussel Inc Nouveaux derives de steroides, leurs procedes de preparation et intermediaires de ce procede, leur application a titre de medicaments et compositions pharmaceutiques les renfermant
DE19929715A1 (de) * 1999-06-24 2000-12-28 Schering Ag 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
FR2826004B1 (fr) * 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes
EP1452293A1 (en) * 2003-02-25 2004-09-01 Mold-Masters Limited Injection molding system with flow control and method of injection molding
DE102009034367A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
CA2813433C (en) 2010-10-27 2019-08-20 Dignity Health Trimegestone (tmg) for treatment of preterm birth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2235949B1 (es) * 1973-06-18 1978-03-17 Roussel Uclaf
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
GB8513723D0 (en) * 1985-05-31 1985-07-03 Erba Farmitalia 11-beta substituted steroids
DE3621024C2 (de) * 1986-06-20 1999-10-28 Schering Ag 11beta-Phenylestradiene, deren Herstellung und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
HU900273D0 (en) 1990-03-28
AU631853B2 (en) 1992-12-10
DE69005480T2 (de) 1994-05-19
US5290771A (en) 1994-03-01
FI900925A0 (fi) 1990-02-23
IL93500A0 (en) 1990-11-29
OA09195A (fr) 1992-06-30
PT93263B (pt) 1996-01-31
TNSN90018A1 (fr) 1991-03-05
MA21754A1 (fr) 1990-10-01
PT93263A (pt) 1990-08-31
EP0384842A1 (fr) 1990-08-29
IE900662L (en) 1990-08-24
EP0384842B1 (fr) 1993-12-29
JPH02268194A (ja) 1990-11-01
DK0384842T3 (da) 1994-03-28
ES2062431T3 (es) 1994-12-16
DE69005480D1 (de) 1994-02-10
KR910015590A (ko) 1991-09-30
PL162151B1 (en) 1993-09-30
FR2643638A1 (fr) 1990-08-31
HUT55032A (en) 1991-04-29
JP3009169B2 (ja) 2000-02-14
US5149696A (en) 1992-09-22
CN1046166A (zh) 1990-10-17
CA2010826A1 (fr) 1990-08-24
FR2643638B1 (fr) 1991-06-14
AU5007290A (en) 1990-08-30
HU207341B (en) 1993-03-29
IE63483B1 (en) 1995-05-03
ZA901356B (en) 1991-04-24
PL283941A1 (en) 1991-01-14
ATE99320T1 (de) 1994-01-15

Similar Documents

Publication Publication Date Title
MX19599A (es) Procedimiento para la preparacion de nuevos 19-nor-esteroides que tienen en posicion 11-beta una cadena carbonada que comprende una funcion amida o carbamato, productos obtenidos y composiciones farmaceuticas preparadas con el producto obtenido.
ES2147238T3 (es) Nuevos analogos estructurales de la vitamina d.
ATE15443T1 (de) Essbare, pharmazeutische zusammensetzungen und verfahren zur herstellung.
IT1281337B1 (it) Preparazione farmaceutica orale contenente ciclosporina come sostanza attiva ed un preconcentrato di emulsione multipla
ES2112988T3 (es) Formulaciones de aerosol que contienen dipropionato de beclometasona sin agentes tensioactivos.
ATE138647T1 (de) 23-oxa-derivate in der vitamin-d-reihe, verfahren zu ihrer herstellung, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung als arzneimittel
PT101725A (pt) Processo para a preparacao de um composto de diarilo anti-aterosclerotico e de composicoes farmaceuticas que o contem
ATE150466T1 (de) Neue 19-nor-steroide mit einer 11-beta- phenoxysulfonamid- oder 11-beta- phenoxysulfonylurea-gruppe, verfahren und zwischenprodukte zu ihrer herstellung sowie medikamenten und pharmazeutische präparate davon
AR216744A1 (es) Nuevos derivados de la fenil-3-oxadiazolina-1,3,4-ona-2,particularmente utiles como agentes activos insecticidas,acaricidas y nematocidas,procedimiento para la preparacion de dichos derivados,composiciones insecticidas,acaricidas y nematocidas que contienen a dichos nuevos derivados
ES2096727T3 (es) Productos cosmeticos y farmaceuticos que contienen extensinas.
PT98681A (pt) Processo para a preparacao de novos 19-nor esteroides que tem na posicao 11b uma cadeia de atomos de carbono com uma funcao amida e de composicoes farmaceuticas que os contem
ATE25849T1 (de) Tricyclophosphazen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
PT90813A (pt) Processo de preparacao de derivados da fenotiazina e de composicoes farmaceuticas que os contem
DE68904491D1 (de) Verwendung von adenosinderivaten zur herstellung von arzneimitteln mit immunstimulierender wirkung.
ATE55123T1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
MX9307009A (es) Derivados de 5-[(imidaol{4,5-b}piridin-3-il]metil/benzofurano, procesopara su preparacion y composiciones farmaceuticas que los contienen.